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STUDY QUESTION: Does oxygen concentration during 3-day embryo culture affect obstetric and neonatal outcomes?
SUMMARY ANSWER: Oxygen concentration during 3-day embryo culture does not seem to affect the obstetric and neonatal out-
comes measured.
WHAT IS KNOWN ALREADY: Atmospheric oxygen appears to be harmful during extended embryo culture. Embryo culture condi-
tions might therefore be a potential risk factor for subsequent fetal development and the health of future children. No data are available
concerning the obstetrics and neonatal outcomes after Day 3 transfer of embryos cultured under reduced and atmospheric oxygen
tensions.
STUDY DESIGN, SIZE, DURATION: A secondary analysis of a previous randomized controlled trial assessing clinical pregnancy out-
comes was carried out. This analysis included 1125 consecutive oocyte donation cycles utilizing ICSI or IVF and Day 3 embryo transfers
between November 2009 and April 2012. The whole cohort of donated oocytes from patients who agreed to participate in the study
were randomly allocated (1:1 ratio) to a reduced O2 tension group (6% O2) or an air-exposed group (20% O2) based on a computer-
generated randomization list. Fresh and vitrified oocytes were used for oocyte donation. Only those pregnancies with a live birth at or be-
yond 24 weeks of gestation were included.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Day 3 embryos were cultured in an atmosphere of 5.5% CO2, 6% O2,
88.5% N2 versus a dual gas system in air.
MAIN RESULTS AND THE ROLE OF CHANCE: From the eligible 1125 cycles, 564 were allocated to the 6% O2 group and 561
cycles to the 20% O2 group. However, 50 and 62 cycles did not reach embryo transfer in the 6% and 20% O2 groups, respectively. No dif-
ferences were found between 6% O2 and atmospheric O2 tension in the number of livebirths per embryo transfer (mean § SD, 0.5§ 0.7
versus 0.5§ 0.7), pregnancy complications or neonatal outcomes. Both groups (6% and atmospheric O2) had similar single and twin deliv-
ery rates (40.8% versus 38.1% and 10.7% versus 12.3%, respectively). Preterm delivery rates and very preterm delivery rates (10.80% ver-
sus 13.24% and 1.25% versus 2.94%, respectively), birthweight (3229§ 561 g versus 3154§ 731 g), low birthweight (2.92% versus 2.45%),
birth height (50.18§ 2.41 cm versus 49.7§ 3.59 cm), head circumference (34.16§ 1.87 cm versus 33.09§ 1.85 cm) and 1 min Apgar
scores (8.96§ 0.87 versus 8.89§ 0.96) were also similar between 6% and atmospheric O2 groups, respectively.
LIMITATIONS, REASONS FOR CAUTION: The number of liveborns finally analyzed is still small and not all obstetric and neonatal
variables could be evaluated. Furthermore, a small proportion of the obstetric and neonatal data was obtained through a questionnaire
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filled out by the patients themselves. One reason for the lack of effect of oxygen concentration on pregnancy outcome could be the ab-
sence of trophectoderm cells at cleavage stage, which may make Day 3 embryos less susceptible to hypoxic conditions.
WIDER IMPLICATIONS OF THE FINDINGS: Nowadays many IVF laboratories use a more physiological oxygen concentration
for embryo culture. However, the benefits of using low oxygen concentration on both laboratory and clinical outcomes during
embryo culture are still under debate. Furthermore, long-term studies investigating the effect of using atmospheric O2 are also needed.
Gathering these type of clinical data is indeed, quite relevant from the safety perspective. The present data show that, at least in egg dona-
tion cycles undergoing Day 3 embryo transfers, culturing embryos under atmospheric oxygen concentration seems not to affect perinatal
outcomes.
STUDY FUNDING/COMPETING INTEREST(S): The present project was supported by the RþD program of the Regional
Valencian Government, Spain (IMPIVA IMDTF/2011/214). The authors declare that they have no conflict of interest with respect to the
content of this manuscript.
TRIAL REGISTRATION NUMBER: NCT 01532193.
Key words: oocyte donation / hypoxia / neonatal outcomes / obstetric outcomes / embryo culture technique / low oxygen tension /
long-term outcomes / Day 3 embryo transfer
Introduction
The use of low oxygen concentration during embryo culture has
been studied extensively owing to its implications for embryo devel-
opment. Human embryos under in vivo conditions are exposed to
low oxygen concentration that varies according to not only the sec-
tion of the reproductive tract but also many other factors, such as
uterine contractility, hormones, the autonomic system, cardiac pul-
satility and myometrial and smooth muscle integrity (Yedwab et al.,
1976; Gosden and Byatt-Smith, 1986; Fischer et al., 1992; Van
Blerkom, 1998; Ng et al., 2018). Culturing embryos under atmo-
spheric tension is considered deleterious for embryo viability. Catt
and Henman (2000) suggested that, at least in theory, three meth-
ods could ultimately help to minimize oxidative damage: decreasing
the oxygen tension in the gas phase during in vitro culture; changing
the formulation media to include antioxidant components; reducing
the incubation time of male and female gametes during insemination
to avoid oxidative damage caused by sperm cell metabolism. The
most recent meta-analysis revealed that although a small improve-
ment (5%) in live birth/ongoing pregnancy and clinical pregnancy
rates is observed when low oxygen concentration is used during
culture, the evidence was of low quality as embryologists were not
blinded and some studies contained important confounding factors
(e.g. different culture conditions and equipment favoring low O2)
(Nastri et al., 2016).
There are increasing concerns about the possible long-term con-
sequences of any type of change we may introduce during ART,
such as changes in oxygen concentration during embryo culture, as
it may impact the health of the next generation. Thus, embryo cul-
ture conditions might be a potential risk factor for subsequent fetal
development and the health of future children (Fleming et al., 2018).
Since birthweight, among other factors, has historically been used as
a marker of neonatal health, we wanted to investigate if atmo-
spheric oxygen conditions could have affected obstetric and neona-
tal outcomes of children conceived after fresh and cryopreserved
Day 3 transfer of embryos cultured under either atmospheric (20%)
or low (6%) oxygen concentration, by performing a secondary
analysis of our previously published randomized controlled trial
(RCT) (NCT 01532193).
Materials and methods
Participants and study design
The present study was approved by the Institutional Review Board at
the Instituto Valenciano de Infertilidad (IVI, Valencia, Spain). This sec-
ondary analysis of a previous RCT was carried out on 1125 consecu-
tive oocyte donation cycles undergoing ICSI or IVF and Day 3 embryo
transfers between November 2009 and April 2012, to compare the
effect of 5.5% CO2, 6% O2 and 88.5% N2 (5.5/6/88.5) versus 5.5%
CO2 and 20% O2 in air. From the initial 1125 cycles eligible for the
study, 564 cycles were randomly allocated to the 6% O2 group and
561 cycles were allocated to the 20% O2 group. However, in the 6%
O2 group, 50 cycles did not reach embryo transfer (35 due to fertiliza-
tion failure/bad oocyte quality, 13 due to endometrial bleeding and
two for other reasons), and in the 20% O2 group, 62 cycles did not
reach embryo transfer (37 due to fertilization failure/bad oocyte qual-
ity, 13 due to endometrial bleeding and 12 for other reasons).
Within the 4-year follow-up period, the maximum number of frozen
embryo transfers (FETs) was four in the low O2 group and five in the
atmospheric O2 tension group. The mean numbers of embryos trans-
ferred in the low O2 and atmospheric O2 groups were 2.46§ 1.21
and 2.28§ 1.15 (mean § SD), respectively (P¼ 0.101), while the
mean number of frozen embryos transferred was 2.14þ 2.29 and
2.01þ 2.20 (mean § SD), respectively (P¼ 0.267).
Finally, a total of 1013 cycles with fresh embryo transfers were in-
cluded in the study (514 in the 6% O2 group and 499 in the 20% O2
group). In each allocation group, those women who did not achieve
pregnancy or had an early miscarriage became pregnant following cry-
otransfer (FET) with the surplus embryos (734 FETs) (Fig. 1).
The inclusion criteria for oocyte recipients were women with good
physical and mental health, aged between 25 and 45 years; first or sec-
ond oocyte recipient treatment; Day 3 embryo transfers; BMI between
18 and 30 kg/m2. The exclusion criteria were uterine pathology or
hydrosalpinx, recurrent miscarriage and chronic illness. Furthermore,
the proportion of smokers did not differ between groups (3.2% in the
6% O2 group versus 1.9% in the 20% O2 group).
The whole cohort of donated oocytes from patients that agreed to
participate in the study were randomly allocated (1:1 ratio) to a re-
duced O2 tension group (6% O2) or an air-exposed group (20% O2)

































































































based on a computer-generated randomization list. Both fresh and vit-
rified oocytes were used for oocyte donation.
Data source and outcome measures
In the low O2 group, the loss to follow-up was 5.9% whereas it was
11.1% in the high-tension group. For frozen cycles, the loss to follow-
up was 4.9% in the low O2 group, whereas in the high O2 tension
group, this rate was 2.7%.
For assessment of pregnancy follow-up, we only included in our
study those pregnancies with a livebirth at or beyond 24 weeks of ges-
tation. Information on the past medical and obstetric history of the
women participating in this study, as well as data on the IVF cycle, was
obtained from computerized clinical charts at IVIRMA Valencia, Spain.
Data on pregnancy follow-up and deliveries were collected mostly
from medical records or reports sent by the doctors caring for the
pregnant women and, in 15% of the cases, through a survey sent to
the patients.
A total of 730 babies were included in the study. There were 444
singleton liveborns (60.8% of the total). A total of 380 (52.1%)
resulted from embryos that had grown under low oxygen tension (6%
O2) and 350 (47.9%) from embryos that had grown under atmo-
spheric air conditions (20% O2). There were 286 twin liveborns
(32.8% of the total), 140 (48.9%) under low oxygen conditions and
146 (51.0%) under atmospheric oxygen concentration (Fig. 1).
The outcome measures were rate of positive b-hCG, clinical preg-
nancy rate, miscarriage rate, ongoing pregnancy rate, obstetric compli-
cations and neonatal outcome. The positive b-hCG/embryo transfer
rate was defined as a serum b-hCG level of at least 50 mIU/ml
12 days after embryo transfer. Clinical pregnancy was defined by the
presence of a gestational sac and fetal heartbeat confirmed by transva-
ginal ultrasound examination at 6–8 weeks of gestation. The miscar-
riage rate was defined as the early miscarriage rate (i.e. pregnancy
losses before 12 weeks of gestation). Ongoing pregnancy was defined
as a viable intrauterine pregnancy after 12 weeks of gestation. The
number of livebirths/embryo transfer was defined as the number of
live newborns per embryo transfer.
The obstetric and neonatal outcome measures were pregnancy
complications (diabetes, hemorrhage, pregnancy-induced hypertension
and premature rupture of membranes), weeks at delivery, type of de-
livery, sex, birthweight (and other related measures), height at birth,
head circumference (cm), Apgar scores, congenital malformations and
puerperal problems including hemorrhagic events and infections.
Information on pregnancy outcome was obtained in all cases but
data on problems occurring during pregnancy could be retrieved in
only 306 patients, 136 from the low O2 group and 170 from the nor-
moxic condition group.
We defined small for gestational age (GA), very small for GA, large
for GA and very large for GA as a birthweight <10th, <3rd, >90th
and >95th percentile, respectively. Low birthweight and very low
birthweight were defined as <2500 g and <1500 g, respectively. Large
birthweight was defined as >4500 g. Birthweight Z-scores were also
calculated. In the case of twin pregnancies, the inter-twin birthweight
disparity was calculated in grams. Preterm births and very preterm
births were defined as those occurring <37 and <32 weeks of gesta-
tion, respectively.
Stimulation protocol for donors
The controlled ovarian stimulation protocol for donors consisted of
administering a daily dose of a GnRH-agonist (decapeptyl, 0.1 mg;
Ipsen Pharma, Barcelona, Spain) in the luteal phase after menses.
Controlled ovarian stimulation was started with 225 IU/day of recom-
binant FSH (Gonal F, Merck Serono; Barcelona, Spain or Puregon,
Shering Plough; Madrid, Spain) or hMG (Menopur, Ferring
Pharmaceutical; Madrid, Spain). The daily dose was adjusted to ovarian
response. Stimulation was continued until the mean diameter of lead-
ing follicles was >18 mm. Recombinant hCG (Ovitrelle, Merck
Serono) was administered and oocyte retrieval was carried out 36 h
later. Anonymous donors were matched to oocyte recipients accord-
ing to phenotype and blood groups. As the use of vitrified oocytes
yields similar clinical outcomes compared to fresh oocytes (Cobo
et al., 2010), both were used for oocyte donation purposes.
Endometrial preparation and oocyte and
embryo handling
The protocol for endometrial preparation differed according to the
presence or absence of ovarian function, as previously described (de
los Santos et al., 2013).
IVF procedures
Four hours after oocyte retrieval, or 2 h after oocyte warming,
oocytes were injected as previously described (Rubio et al., 1997).
ICSI was performed at 400 magnification with a 1X7 Olympus mi-
croscope. Based on the allocation group, both oocytes and embryos
were culture equilibrated under oil in a 50 ml drop of Sydney IVF
cleavage media (COOK) (Limerick, Ireland), which had been previ-
ously equilibrated overnight in the respective gas mixtures and then in-
cubated in Sanyo MCI 5M incubators (Etten-Leur, the Netherlands)
set at either 6% O2 or 20% O2 under a humidified environment.
















340 FET***  
89 SLB **
36 TLB
Figure 1. Flowchart showing the origins of all live births
studied. *TLBs correspond to the number of babies born from twin
pregnancies. **SLBs correspond to the number of babies born from
single pregnancies. ***Number of total fresh embryo transfers per-
formed (including all attempts per group). ITT, intention to treat; ET,
embryo transfer; FET, frozen embryo transfer; SLB, single liveborn;
TLB, twin liveborn.


























































The sample size estimation for the initial published study (de los
Santos et al., 2013) was based on an expected 10% increase in the
clinical pregnancy rate per cycle following culture with a reduced O2
concentration. Analysis based on a two-sided significance level with a
of 0.05 and a b error of 0.2% showed that at least 380 cycles were re-
quired per arm.
From the total number of births achieved in our first publication,
rates of neonatal and obstetric outcomes and the corresponding risk
ratios (RRs) with 95% CI were calculated. A Poisson regression was
performed to calculate the RRs.
Data are presented as mean § SD or n (%). The differences in out-
comes between groups were tested by the Student’s t-test for contin-
uous variables and Fisher’s exact test for binomial variables. A P value
of <0.05 was considered statistically significant. R statistical software
package version 3.5.3 was used for statistical analysis.
Results
IVF outcomes
A total of 524 pregnant women participated in this study
(Supplementary Table SI). Small but significant differences were found
in their BMIs. No differences were found regarding the cause of infer-
tility between women in the reduced and atmospheric oxygen groups.
The IVF outcomes after fresh embryo transfer were similar in both
study groups. Long-term follow-up of the initial pregnancies showed
no significant impact of culture conditions on the mean LBs per trans-
fer and the LB rate per intention to treat (ITT) cycle (Table I).
In FET cycles (Supplementary Table SII), no statistically significant
differences were found after transfer of cryopreserved embryos cul-
tured under either oxygen concentration. Only the number of em-
bryos transferred appeared to be marginally significant (P¼ 0.05).
Similar results were found when taking fresh embryo transfers and
FETs into consideration. Embryos cultured under low oxygen did
not yield higher pregnancy, ongoing pregnancy and delivery rates
per ITT compared to embryos grown under atmospheric oxygen
tension (Table II).
In the low O2 group, the loss to follow-up was 5.9%; loss was
11.1% in the high-tension group. For frozen cycles, the loss to follow-
up in the low O2 group was 4.9%; in the high O2 tension group, this
rate was 2.7%.
Obstetric outcomes
In this study, we analyzed twin and singleton pregnancies together be-
cause we had the same proportion of twin pregnancies in each group
(10.5% in the 6% oxygen group versus 12.3% in the 20% oxygen
group; P ¼ NS). In the fresh embryo transfers and FET groups with
singleton deliveries, no differences were found in the cesarean section
rate (70.33% and 68.57%, respectively, in the 20% oxygen group ver-
sus 58.47% and 55.13%, respectively, in the 6% oxygen group, P ¼
NS). However, the proportion of cesarean sections was higher in twin
deliveries with both fresh embryo transfers and FET (Supplementary
Table SII, SIII, SIV, SV and SIV).
The incidence of diabetes in pregnancy (11.8% versus 11.8%), first,
second and third trimester bleeding (39.7% versus 38.8%), premature
rupture of membranes (9.6% versus 7.1%), pregnancy-induced hyperten-
sion (12.5% versus 15.2%) and puerperal problems (8.1% versus 10%)
was similar in the 20% and 6% oxygen groups, respectively (P ¼ NS).
............................................................................................................................................................................................................................
Table I IVF outcomes following fresh embryo transfers.
6% O2 20% O2 RR [95% CI] P
Number of cycles (ITT) 564 561
Number of fresh ETs 514 499
Positive b-hCG/fresh ET 318 (61.9%) 303 (60.7%) 1.02 [0.92, 1.12] 0.71
Clinical pregnancy/fresh ET 276 (53.7%) 263 (52.7%) 1.02 [0.91, 1.14] 0.75
Ongoing pregnancy/fresh ET 233 (45.3%) 227 (45.5%) 1.00 [0.87, 1.14] 1
Miscarriage/fresh ET 83 (16.2%) 73 (14.6%) 1.10 [0.83, 1.47] 0.50
Clinical miscarriage/fresh ET 41 (8.0%) 34 (6.8%) 1.17 [0.76, 1.81] 0.48
Multifetal pregnancy/fresh ET 84 (16.34%) 105 (21.04%) 0.77 [0.59, 1.00 ] 0.06
Reduction of yolk sac/fresh ET 15 (3.2%) 14 (3%) 1.04 [0.51, 2.14] 0.91
Number of embryos transferred/fresh ET 1.9 § 0.3 1.9 § 0.3 0.45
LB mean/fresh ET 0.5 § 0.7 0.5 § 0.7 0.88
Perinatal mortality/fresh ET 0 (0%) 1 (0.2%) 0.99
Total deliveries/fresh ET 198 (40.8%) 170 (38.1%) 1.07 [0.91, 1.26] 0.40
Twin deliveries/fresh ET 51 (10.5%) 55 (12.3%) 0.85 [0.59, 1.22] 0.38
Total deliveries/ITT 198 (37.0%) 170 (33.5%) 1.11 [0.94, 1.30] 0.24
Liveborns/fresh ET 249 (0.44) 279 (0.40) 0.88
ET, embryo transfer; ITT, intention to treat; LB: live birth; RR, risk ratio.
Data are expressed as n (%) or mean § SD. The RR was calculated with the 20% oxygen group as the reference group. The P values were calculated with Fisher’s exact test.
Deliveries per ITT were calculated considering the cases of loss to follow-up.





























No differences were found between the study groups in the GA at
delivery, preterm birth and very preterm birth rates in singleton and
twin pregnancies (Tables III and IV).
Neonatal outcomes
Regarding the neonatal endpoints of this study, no statistical differences
were observed between the study groups. The prevalence of congeni-
tal malformations was similar between O2 groups. Apart from those
registered at birth (Tables III and IV), there were three terminations of
pregnancy because of fetal abnormalities: two in the low oxygen group
(a case of acrania and a case of chromosome 2 microdeletion—
Feingold syndrome) and one in the high oxygen group (a case of acra-
nia). Similar sex ratios, birthweight (analyzed in different ways), head
circumference and Apgar scores were also found in singletons and
twins in the two O2 groups (Tables III and IV). Likewise, no differences
in sex ratio, birthweight, head circumference or Apgar scores were
observed when analyzing the fresh embryo transfer and FET groups
separately (Supplementary Tables SIII, SIV, SV and SVI).
Discussion
The concentrations of oxygen in vivo (in follicular fluids, fallopian tubes
and uterine cavities) (Yedwab et al., 1976; Fischer et al., 1992;
............................................................................................................................................................................................................................
Table III Pregnancy outcomes of liveborn singletons from fresh ET and frozen embryo transfers.
6% O2 20% O2 RR [95% CI] P
Number of SLBs 240 204
Females 105 (43.75%) 93 (45.59%) 0.95 [0.77, 1.18] 0.69
Preterm births (<37 w) 26 (10.8%) 27 (13.24%) 0.81 [0.49, 1.35] 0.43
Very preterm births (<32 w) 3 (1.25%) 6 (2.94%) 0.43 [0.11, 1.67] 0.22
Weeks at delivery 39.04 § 2.03 38.67 § 3.0 0.36 [0.11, 0.85] 0.13
Birthweight (g) 3229 § 561 3154 § 731 75.85 [0.60, 1.05] 0.26
Low birthweight (<2500 g) 17 (7.08%) 22 (10.78%) 0.65 [0.35, 1.20] 0.17
Low birthweight at term 7 (2.92%) 5 (2.45%) 1.19 [0.38, 3.69] 0.76
Very low birthweight (<1500 g) 2 (0.83%) 7 (3.43%) 0.24 [0.05, 1.15] 0.07
Large birthweight (>4500 g) 2 (0.83%) 3 (1.47%) 0.57 [0.09, 3.35] 0.53
Small for gestational age (birthweight <p10) 19 (9.36%) 17 (10.69%) 0.87 [0.47, 1.62] 0.67
Very small for gestational age (birthweight <p3) 9 (4.43%) 5 (3.14%) 1.41 [0.48, 4.21] 0.52
Large for gestational age (birthweight >p90) 33 (16.26%) 28 (17.61%) 0.75 [0.45, 1.26] 0.28
Very large for gestational age (birthweight >p95) 17 (8.37%) 11 (6.92%) 1.21 [0.58, 2.51] 0.60
Birthweight Z-score 0.03 § 1.15 0.08 § 1.47 0.04 [0.21, 0.31] 0.72
Height (cm) 50.18 § 2.41 49.67 § 3.59 0.49 [0.21, 1.20] 0.17
Head circumference (cm) 34.16 § 1.87 33.90 § 1.85 0.26 [0.30, 0.83] 0.36
1 min Apgar score 8.96 § 0.87 8.89 § 0.96 0.07 [0.17, 0.31] 0.57
5 min Apgar score 9.71 § 0.61 9.65 § 0.63 0.06 [0.12, 0.24] 0.50
10 min Apgar score 9.98 § 0.43 9.75 § 0.43 0.08 [0.08, 0.26] 0.33
Cesarean sections 96 (40.00%) 98 (48.04%) 0.92 [0.66, 1.02] 0.08
Congenital malformations (major and minor) 8 (3.35%) 6 (2.96%) 1.13 [0.39, 3.21] 0.81
Data are expressed as n (%) or mean § SD. The RRs were calculated with the 20% oxygen group as the reference group. The P values were calculated with Fisher’s exact test or the
Student’s t-test, where appropriate.
p3, third percentile; p10, 10th percentile; p90, 90th percentile; p95, 95th percentile; SLB, singleton liveborn; w, weeks.
............................................................................................................................................................................................................................
Table II Cumulative IVF outcomes of all ETs.
6% O2 20% O2 RR [95% CI] P
Number of cycles 564 561
Positive b-hCG/ITT 411 (72.87%) 390 (69.52%) 1.048 [0.97, 1.13] 0.24
Clinical pregnancy/ITT 381 (67.55%) 357 (63.64%) 1.062 [0.96, 1.16] 0.17
Ongoing pregnancy/ITT 328 (58.16%) 310 (55.26%) 1.052 [0.95, 1.166] 0.34
Total deliveries/ITT 277 (49.11%) 247 (44.03%) 1.115 [0.984, 1.265] 0.094
Poisson regression was used to calculate the proportions, RRs and P values. Data are expressed as n (%).

















































..Waldenström et al., 2009) are much lower than those currently used
in many IVF laboratories, which are based on atmospheric oxygen
concentration and may provoke a certain degree of toxicity to the em-
bryos (Catt and Henman, 2000). Although improvements have been
incorporated into in vitro embryo culture and, as a result, clinical out-
comes have significantly improved over the years (Swain, 2010, 2012;
Nastri et al., 2016), oxygen concentration is considered a critical pa-
rameter in in vitro culture systems. In fact, some studies in mice
revealed that embryos generated under 5% oxygen more closely re-
semble in vivo-developed embryos (Garrisi et al., 1993; Rinaudo et al.,
2006). In rhesus monkeys, the O2 partial pressure is lower in the
uterus (18 mmHg) than in the fallopian tubes (58 mmHg), but
data comparing these compartments in humans are limited. However,
what is reported so far is that the uterine measurements of oxygen
partial pressure (ppO2) vary from 6.6 to 32 mmHg and increase by
the time of ovulation and in the luteal phase. In any case, these values
are far from the atmospheric ppO2, which is 750 mmHg (Ottosen
et al., 2006).
The underlying mechanism by which the use of atmospheric oxygen
may be harmful for human embryos was inferred from animal studies.
These studies revealed that low oxygen concentration during embryo
culture could be beneficial to gene expression patterns, the proteome,
energy metabolism or the methylome (Katz-Jaffe et al., 2005; Rinaudo
et al., 2006; Wu and Zhang, 2010; de los Santos et al., 2015; Kaser
et al., 2018). In the early stages, 20% oxygen was associated with an
overall increase in amino acid turnover and pyruvate uptake by mouse
embryos. In contrast, after compaction, 20% oxygen was related to a
decrease in amino acid turnover and glucose uptake (Kaser et al.,
2018). Some studies show clear evidence suggesting that global loss of
DNA methylation of the paternal genome is attributable to Tet-
mediated oxidation. Tet proteins contribute to dynamic changes in
DNA methylation, and gene expression studies will enhance our under-
standing of epigenetic regulation (Wu and Zhang, 2010; de los Santos
et al., 2015; Kaser et al., 2018). There are few studies comparing re-
duced and atmospheric oxygen culture conditions in humans. Studies
looking at the metabolic fingerprint of good quality Day 3 human em-
bryos showed that, at least in terms of net depletion or release of
some relevant analytes such as glucose or fatty acids (Katz-Jaffe et al.,
2005; de los Santos et al., 2015), no differences were found between
low O2 and normoxic embryo culture conditions. More recent data in
human blastocysts have demonstrated that, at the blastocyst stage,
even small variations of oxygen during culture (from 5% to 2%) impact
the relative abundances of anabolic amino acids and metabolites in-
volved in redox homeostasis by upregulating mucin 1, showing that ox-
ygen influences embryo metabolism and may be important, at least at
this more differentiated stage of development (Kaser et al., 2018).
Therefore, the question remains of whether the plasticity or adapt-
ability that embryos are able to demonstrate in vitro may also account
for their oxygen resilience, at least at preimplantation stages, and their
ability to implant after embryo transfer. In addition, the use of ultralow
oxygen concentrations, which is an even more physiological approach
for embryo culture, yields inconclusive results (Kaser et al., 2016,
............................................................................................................................................................................................................................
Table IV Pregnancy outcomes of liveborn twins from fresh ET and frozen embryo transfers.
6% O2 20% O2 RR [95% CI] P
Number of TLBs 140 146
Females 69 (49.2%) 70 (47.9%) 1.02 [0.81, 1.30] 0.82
Preterm births (<37 w) 86 (61.43%) 84 (57.5%) 1.06 [0.88, 1.29] 0.50
Very preterm births (<32 w) 9 (5.71%) 10 (6.85%) 0.83 [0.33, 2.05] 0.69
Weeks at delivery 35.88 § 2.56 35.87 § 2.73 0.0 [0.61, 0.63] 0.97
Birthweight (g) 2312 § 498 2318 § 569 5.4 [14.2, 131.2] 0.93
Low birthweight (<2500 g) 69 (49.2%) 73 (50.0%) 0.98 [0.78, 1.24] 0.90
Low birthweight at term 13 (9.29%) 20 (13.7%) 0.67 [0.35, 1.31] 0.24
Very low birthweight (<1500 g) 8 (5.71%) 10 (6.85%) 0.83 [0.39, 2.05] 0.69
Large birthweight (>4500 g) 1 (0.88%) 3 (2.05%) 0.35 [0.0, 3.41] 0.37
Small for gestational age (birthweight <p10) 34 (30.09%) 40 (27.40%) 0.91 [0.62, 1.34] 0.65
Very small for gestational age (birthweight <p3) 18 (15.9%) 15 (10.27%) 1.49 [0.76, 2.90] 0.23
Large for gestational age (birthweight >p90) 1 (0.88%) 3 (0.22%) 0.35 [0.03, 3.41] 0.37
Very large for gestational age (birthweight >p95) 0 (0%) 1 (0.7%) NA 1
Birthweight Z-score 1.00 § 1.18 0.94 § 1.00 0.15 [0.44, 0.11] 0.26
Height (cm) 46.96 § 2.77 45.99 § 4.03 0.96 [0.21, 2.14] 0.11
Head circumference (cm) 32.44 § 1.50 32.45 § 2.23 0.01 [0.79, 0.77] 0.97
1 min Apgar score 8.70 § 0.94 8.46 § 1.34 0.28 [0.19, 0.67] 0.28
5 min Apgar score 9.48 § 0.72 9.58 § 0.62 0.10 [0.35, 0.14] 0.41
10 min Apgar score 9.70 § 0.72 9.62 § 0.65 0.04 [0.46, 0.53] 0.88
Cesarean sections 13 (38.1%) 2 (10%) 3.81 [0.91, 15.81] 0.07
Congenital malformations (major and minor) 5 (3.57%) 6 (4.11%) 0.86 [0.27, 2.78] 0.81
Data are expressed as n (%) or mean § SD. The RRs were calculated with the 20% oxygen group as the reference group. The P values were calculated with Fisher’s exact test or the
Student’s t-test, where appropriate.
TLB, liveborn twins.

































































































2018; Morin 2017). Kaser et al. (2016) suggested that blastocyst yield
and quality may be superior when O2 tension is reduced from 5% to
2% on Day 3. Thus, they proposed sequential oxygen exposure (5%
from Days 1 to 3, then 2% from Days 3 to 5) (Kaser et al., 2016).
Regarding clinical outcomes, the use of a low oxygen environment
showed the benefits of a more physiological approach, especially for
blastocyst culture (Nastri et al., 2016). However, this recent meta-
analysis found low-quality evidence that low O2 is better for live birth/
ongoing pregnancy [risk ratio (RR) ¼ 1.1, 95% CI 1.0–1.3] and clinical
pregnancy (RR ¼ 1.1, 95% CI 1.0–1.2) compared to atmospheric O2
concentration. Some examples of study flaws include the use of differ-
ent incubators (a new model for the low O2 group and an old model
for the normoxic group), the unblinding of embryologists and the lack
of rigor regarding random sequence generation and group allocation
(Nastri et al., 2016).
Studies on the long-term effect of using atmospheric O2 are missing
and gathering these types of data is important, especially when there
are increasing concerns about the possible long-term consequences of
any type of change we may introduce during in vitro human embryo
culture, as has been suggested regarding the use of culture media or
some of its components (Dumoulin et al., 2010; Zandstra et al., 2015;
Marianowski et al., 2016; Thompson et al., 2016).
In this study, we wanted to know whether the use of low or atmo-
spheric O2 concentration in our previous RCT had an impact on the
pregnancies achieved during the study and their neonatal outcomes.
As far as we know, no previous report has looked at the relevant
obstetric and neonatal outcomes following use of two different oxygen
concentrations during embryo culture.
Our singleton and twin oocyte donation pregnancies following nor-
moxic embryo culture had similar pregnancy complications, GA at de-
livery, preterm birth rate, birthweight, low birthweight rate, small for
GA rate and Apgar scores as those previously reported in pregnancies
following vitrified oocyte donation (Cobo et al., 2014). The cesarean
section rates were similarly high. Likewise, although limited data on
obstetric complications were gathered, our data are comparable with
previous reports by our group (Cobo et al., 2014) and others (De
Munck et al., 2016) describing oocyte donation programs using fresh
and/or vitrified oocytes.
Placenta-mediated pregnancy complications, including pre-eclampsia,
birth of a small for GA child, placental abruption or late pregnancy
loss, are common (Maheshwari et al., 2013; Bidarimath and Tayade,
2017; Kingdom et al. 2018; Sultana et al., 2018). Oxygen also seems
to be very important in placental development and function (Pinborg
et al., 2013). Trophoblast culture under different oxygen concentra-
tions has an impact on the invasive phenotype in vitro (Udayashankar
et al., 2011). However, based on our results, culturing cleavage-stage
human embryos at atmospheric O2 concentration did not influence
these placenta-derived complications. One reason for the lack of effect
of oxygen concentration on pregnancy outcome in this study could be
the absence of trophectoderm cells (known precursors of the pla-
centa), which may make Day 3 embryos less susceptible to hypoxic
conditions. Future inquiries will be necessary to address the impact of
low and high oxygen concentration at the blastocyst stage, when the
initial steps of trophoblast differentiation have already started, although
embryonic genome activation and metabolism changes start at cleav-
age stages (Devreker and Englert, 2000; Stokes et al., 2005; Ménézo
et al., 2010). Another possibility may be that placenta-associated
pregnancy complications are not affected by the culture conditions and
are more influenced by maternal related factors.
Additionally, no differences were observed in live birth rates or neo-
natal outcomes between the two study groups. Neonatal outcomes
were analyzed according to the multiplicity of the pregnancies. In the
present study, we did not find any significant statistical dissimilarities
between the 6% and 20% O2 groups, either among singleton or twin
pregnancies. Transfer of more than one embryo may decrease the
birthweight of singletons (Kliegman et al., 1990; Grady et al., 2012;
Pinborg et al., 2013). In our case, a similar number of embryos was
transferred in both groups.
We do not have an exact explanation for the high proportion of
cesarean deliveries for twin pregnancies in both oxygen groups, as de-
liveries took place in different hospitals. However, many of these pre-
gnancies were considered high-risk owing to other factors (advanced
maternal age, oocyte donation, multiple pregnancy, cryopreservation,
etc.) and this might have also influenced the mode of delivery.
Additionally, a previously published series of oocyte donation pregnan-
cies also showed a high prevalence of cesarean deliveries (Cobo et al.,
2014).
Birthweight has historically been used as a marker of neonatal health
(Kliegman et al., 1990). Neonatal outcomes of singletons after assisted
reproduction, such as congenital malformations, perinatal mortality and
birthweight among others, are poorer than those of children conceived
spontaneously (Kliegman et al., 1990; Grady et al., 2012; Henningsen
and Pinborg, 2014; De Munck et al., 2016; Qin et al., 2016). Birthweight
seems to be lower after ART than with spontaneous conception, but
there are differences between ART techniques. For instance, thawed
embryo transfers seem to result in higher birthweight (Qin et al., 2016)
and better perinatal outcomes than fresh embryo transfers (Maas et al.,
2016). Apart from the use of cryopreservation, other variables such as
the culture medium, the stage of the embryo at transfer, or the number
of embryos being transferred should also be considered.
Our data show that, in singletons, not only does the oxygen con-
centration during culture have no effect on birthweight, but the cryo-
preservation procedure has no consequence either. These data do
not support previous published data comparing fresh and cryopre-
served cycles (Pinborg et al., 2013; Maas et al., 2016) but agree on the
fact that birthweight does not seem to be affected by culture condi-
tions when fresh transfers are performed (Maas et al., 2016), despite
differences in pregnancy rates.
We need to acknowledge some limitations of our study. The number
of pregnancies analyzed was small and data on pregnancy problems
could not be retrieved for all patients. Furthermore, a small proportion
of the obstetric and neonatal data was obtained through a question-
naire filled out by the patients themselves. Despite these limitations, we
believe this is the largest series published so far on this issue.
In conclusion, our limited data show promising results suggesting no
apparent effect on live birth and neonatal outcomes when a high oxy-
gen concentration is used at early stages (Day 3) of embryo develop-
ment, at least in the oocyte donation cycle. Data from blastocyst
transfers under normoxic and hypoxic conditions need to be reported
to better understand the long-term consequences of the atmospheric
O2 environment during culture.
Given the above, our results are interesting because presently, de-
spite the recommendations of single blastocyst transfer, many patients
come to the ART clinics to achieve pregnancy through oocyte

































































































donation and Day 3 embryo transfers. Thus, it is important to analyze
the potential impact, if any, of embryo culture conditions on the long-
term health of the children conceived through these in vitro
techniques.
Supplementary data
Supplementary data are available at Human Reproduction online.
Authors’ roles
M.R.A. exploited the data base, participated in the elaboration of
tables and figures and data analyses. V.S. supervised the clinical data,
wrote the manuscript and gave the final approval of the manuscript.
P.G. cultured embryos, participated in the laboratory and clinical data
entry. J.M.D.L.S. participated in the quality control of the laboratory
equipment and in the clinical data entry. J.R. gave the final approval of
the manuscript. A.T.N. made the statistical analyses. M.J.D.L.S. con-
ceived, supervised the project, wrote the manuscript.
Acknowledgments
We would like to thank the embryology team at the Clinic of IVI
Valencia for their excellent clinical assistance. We also thank Dr
Francesc Figueras (Hospital Clinic, Barcelona, Spain) and the British
Perinatal Institute for Maternal and Child Health for providing the tools
to calculate birthweight percentiles.
Funding
The present project was supported by the RþD program of the
Regional Valencian Government, Spain (IMPIVA IMDTF/2011/214).
Conflict of interest
The authors declare that they have no conflict of interest with regard
to the content of this manuscript.
References
Bidarimath M, Tayade C. Pregnancy and spontaneous fetal loss: a pig
perspective. Mol Reprod Dev 2017;84:856–869.
Catt JW, Henman M. Toxic effects of oxygen on human embryo de-
velopment. Hum Reprod 2000;15(Suppl 2):199–206.
Cobo A, Meseguer M, Remohı́ J, Pellicer A. Use of cryo-banked
oocytes in an ovum donation programme: a prospective, random-
ized, controlled, clinical trial. Hum Reprod 2010;25:2239–2246.
Cobo A, Serra V, Garrido N, Olmo I, Pellicer A, Remohı́ J. Obstetric
and perinatal outcome of babies born from vitrified oocytes. Fertil
Steril 2014;102:1006–1015.e4.
de los Santos MJ, Gámiz P, Albert C, Galán A, Viloria T, Pérez S,
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